MEDIFAST INC (MED) Social Stream
MEDIFAST INC (MED) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering MED.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2022-02-23 | 2 | $349 | $345 | $347 | $68.74 | 404.8% |
2022-05-03 | 2 | $345 | $341 | $343 | $68.74 | 398.98% |
2022-06-02 | 2 | $352 | $345 | $348.5 | $68.74 | 406.98% |
2022-08-05 | 1 | $278 | $278 | $278 | $68.74 | 304.42% |
2022-11-07 | 1 | $106 | $106 | $106 | $68.74 | 54.2% |
2023-02-22 | 1 | $94 | $94 | $94 | $68.74 | 36.75% |
2023-05-03 | 1 | $71 | $71 | $71 | $68.74 | 3.29% |
2023-06-22 | 1 | $75 | $75 | $75 | $68.74 | 9.11% |
2023-08-01 | 1 | $93 | $93 | $93 | $68.74 | 35.29% |
2023-08-08 | 1 | $80 | $80 | $80 | $68.74 | 16.38% |
2023-10-13 | 2 | $82 | $80 | $81 | $68.74 | 17.84% |
2023-11-07 | 2 | $82 | $67 | $74.5 | $68.74 | 8.38% |
2023-12-01 | 2 | $79 | $67 | $73 | $68.74 | 6.2% |
The Trend in the Analyst Price Target
Over the past 35 months, MED's average price target has gone down $163.
Over the past 40 weeks, MED's average upside potential has been -5.6%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-05-02 | 1 | 71 | 71 | 71.0 | 88.16 | -19.46% |
2023-05-03 | 1 | 71 | 71 | 71.0 | 85.20 | -16.67% |
2023-06-22 | 1 | 75 | 75 | 75.0 | 87.98 | -14.75% |
2023-11-07 | 2 | 82 | 67 | 74.5 | 68.89 | 8.14% |
2023-12-01 | 2 | 79 | 67 | 73.0 | 68.31 | 6.87% |
MED Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
3 | 0 | 0 | 2 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 43 months, MED's average broker recommendation rating worsened by 0.67.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, MEDIFAST INC's number of analysts covering the stock is higher than 19.81% of them.
- MED has a lower variance in analysts' estimates than 8.56% of Consumer Cyclical stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, MEDIFAST INC's average analyst price target is greater than 1225.62% of them.
- In the context of Food Products stocks, MEDIFAST INC's upside potential (average analyst target price relative to current price) is greater than 888.99% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Food Products industry with the ratings most similar to MEDIFAST INC are TR, BRBR, and SMPL.
View All Top Stocks by Price Target
What is the outlook for MED? Use POWR Ratings for clearer insight into price direction.